Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study
Wenzhe Fan(Chongqing Normal University), Jiaping Li(Sun Yat-sen University), Zhuoyong Li(Jiangmen Central Hospital), Xinlin Zheng(Sun Yat-sen University), Lei Yu(Taiyuan Central Hospital), Wanchang Huang(First People's Hospital of Nanning), Yanqin Wu(Fujian Medical University), Guosheng Yuan(Nanfang Hospital), Yu Cheng(The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture), Wenjiang Wei(Guangdong Provincial People's Hospital), Bowen Zhu(Sun Yat-sen University), Huishuang Fan(Dongguan People’s Hospital), Fuliang Li(Northeastern University), Shu‐Gui Huang(First Affiliated Hospital of Guangdong Pharmaceutical University), Yingqiang Zhang(Sun Yat-sen University), Fuxi Huang(Panyu District Central Hospital), Hongyu Wang(Guangzhou University of Chinese Medicine), Rong Tang(Tulane University), Xinhua Zou(Sun Yat-sen University), Zhen Huang(Nanjing University of Science and Technology), Liangliang Qiao(Guangzhou University of Chinese Medicine), Miao Xue(Sun Yat-sen University), Shufan Yue(Sun Yat-sen University)
Cited by 10
Related Papers
Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study.
|PubMed|2003|1k
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295